Susquehanna International Group, LLP Genocea Biosciences, Inc. Transaction History

Susquehanna International Group, LLP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 16, 2020	SELL	$1.81 - $5.53 $7,826 - $23,911	-4,324 Reduced 7.11%	56,458 $129,000
Q2 2020 Aug 14, 2020	SELL	$1.66 - $3.06 $5,853 - $10,789	-3,526 Reduced 5.48%	60,782 $140,000
Q1 2020 May 15, 2020	BUY	$1.26 - $2.73 $27,662 - $59,934	21,954 Added 51.83%	64,308 $111,000
Q3 2019 Nov 14, 2019	BUY	$2.9 - $4.07 $72,302 - $101,473	24,932 Added 143.11%	42,354 $123,000
Q2 2019 Nov 14, 2019	BUY	$3.47 - $6.71 $60,454 - $116,901	17,422 New	17,422 $68,000

10K

Ticker GNCA
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,783,500
Description
Genocea Biosciences, Inc., a biopharmaceutical company, discovers and develops novel cancer immunotherapies. The company uses its proprietary discovery platform, ATLAS, which profiles each patient's CD4+ and CD8+ T cell immune responses to every target or antigen identified by next-generation sequencing of that patient's tumor. Its products incl...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.